Tags

Type your tag names separated by a space and hit enter

Amantadine in Parkinson's disease. Review of more than two years' experience.
JAMA. 1972 Nov 13; 222(7):792-5.JAMA

Authors

Schwab RS
No affiliation info available
Poskanzer DC
No affiliation info available
England AC
No affiliation info available
Young RR
No affiliation info available

MeSH

AgedAmantadineAtaxiaConstipationDepressionDiarrheaDihydroxyphenylalanineDrug SynergismEvaluation Studies as TopicFemaleHeadacheHumansMaleMiddle AgedParasympatholyticsParkinson DiseaseTime FactorsTremor

Pub Type(s)

Journal Article

Language

eng

PubMed ID

4677928

Clinical Trial Links

Open-Label Safety Study of ADS-5102 in PD Patients With LID

Citation

Schwab, R S., et al. "Amantadine in Parkinson's Disease. Review of More Than Two Years' Experience." JAMA, vol. 222, no. 7, 1972, pp. 792-5.
Schwab RS, Poskanzer DC, England AC, et al. Amantadine in Parkinson's disease. Review of more than two years' experience. JAMA. 1972;222(7):792-5.
Schwab, R. S., Poskanzer, D. C., England, A. C., & Young, R. R. (1972). Amantadine in Parkinson's disease. Review of more than two years' experience. JAMA, 222(7), 792-5.
Schwab RS, et al. Amantadine in Parkinson's Disease. Review of More Than Two Years' Experience. JAMA. 1972 Nov 13;222(7):792-5. PubMed PMID: 4677928.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Amantadine in Parkinson's disease. Review of more than two years' experience. AU - Schwab,R S, AU - Poskanzer,D C, AU - England,A C,Jr AU - Young,R R, PY - 1972/11/13/pubmed PY - 2001/3/28/medline PY - 1972/11/13/entrez SP - 792 EP - 5 JF - JAMA JO - JAMA VL - 222 IS - 7 SN - 0098-7484 UR - https://www.unboundmedicine.com/medline/citation/4677928/full_citation DB - PRIME DP - Unbound Medicine ER -